The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New agency agreement for IMPACT

18 Jul 2018 07:00

RNS Number : 9566U
mporium Group PLC
18 July 2018
 

18 July 2018

Mporium Group plc

("Mporium" or the "Group")

New agency agreement for IMPACT

Mporium Group plc (AIM:MPM), the technology firm delivering event-driven marketing, is pleased to announce an agreement to provide its IMPACT technology product to one of the world's largest and most prestigious media services networks. The network provides services to over 5,000 clients in more than 100 countries and is a key division of one of the largest global marketing communications groups.

Following a successful trial with one of the agency's top-tier clients, an agreement has been signed which will see IMPACT commercially rolled out across this client's campaigns as well as deploying IMPACT across other clients of the network. The client is one of the world's largest companies, appearing within the top 20 of the Forbes Global 2000.

Mporium's proprietary technology, IMPACT, enables advertisers, and the agencies that serve them, to identify and leverage micro-moments; those moments when there are significant changes in the levels of consumer intent. The result is improved performance for digital advertising campaigns, from brand advertising to direct response.

IMPACT leverages a range of signals, including TV, news, sports and social media to manage in real-time the pricing, timing and selection of content for digital advertising campaigns.

Mporium's Chief Executive, Nelius De Groot, said:

"I am delighted to announce this agreement with one of the largest and most prestigious media services networks. We have already proven that Mporium's technology can help this network achieve their focus of delivering growth for their clients.

This agreement also represents another important milestone for Mporium, as it extends our contractual relationships to include another of the largest agency networks."

Enquiries

 

Mporium:

020 3841 8411

Nelius De Groot, Chief Executive Officer

finnCap Ltd:

020 7220 0500

Henrik Persson

Kate Bannatyne

Andrew Burdis

Alma PR:

020 3865 9668

Rebecca Sanders-Hewett

Josh Royston

Susie Hudson

Sam Modlin

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

Notes to editors

About Mporium

Mporium is a technology company at the forefront of the transformation in digital marketing. Mporium's proprietary technology enables advertisers, to identify and monetise micro-moments - those moments when there are significant changes in the levels of consumer intent. These micro-moments are used to drive highly performant digital advertising campaigns: from brand advertising to direct response.

Based in the UK, Mporium Group plc is quoted on AIM, the junior market of the London Stock Exchange plc.

www.mporium.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRGGUGPMUPRPGM
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.